ACR Appropriateness Criteria Dementia and Movement Disorders
Franz J Wippold1, Douglas C Brown2, Daniel F Broderick3
1Mallinckrodt Institute of Radiology, St Louis, Missouri.
Journal of the American College of Radiology : JACR
|January 6, 2015
Summary
Neuroimaging plays a role in ruling out reversible causes of dementia and movement disorders. While not always specific for differentiating neurodegenerative diseases, advanced techniques offer future research potential.
Area of Science:
- Neurology
- Radiology
- Medical Imaging
Background:
- Neurodegenerative diseases like dementia are a growing public health concern.
- Anatomic neuroimaging is crucial for identifying reversible structural causes in patients with dementia or movement disorders.
- Current neuroimaging techniques often lack the sensitivity and specificity to differentiate between various neurodegenerative disorders.
Purpose of the Study:
- To evaluate the role of neuroimaging in the diagnosis and understanding of neurodegenerative diseases.
- To discuss the limitations and potential of current and advanced neuroimaging techniques in clinical practice and research.
- To highlight the evidence-based approach of the ACR Appropriateness Criteria in guiding neuroimaging use.
Main Methods:
- Review of current medical literature from peer-reviewed journals.
- Application of a modified Delphi consensus methodology by a multidisciplinary expert panel.
- Analysis of the ACR Appropriateness Criteria for neuroimaging in specific clinical conditions.
Main Results:
- Neuroimaging is primarily used to exclude reversible structural causes of dementia and movement disorders.
- Existing neuroimaging methods have limitations in differentiating specific neurodegenerative conditions.
- Advanced functional neuroimaging techniques show promise for future research but are not yet routine clinical practice.
Conclusions:
- Neuroimaging is valuable for research into neurodegenerative disorders, offering insights into brain structure and function.
- Functional neuroimaging, including MRI and MR spectroscopy, presents significant potential for advancing the understanding of these conditions.
- The ACR Appropriateness Criteria provide evidence-based guidelines, utilizing expert opinion when definitive evidence is lacking, to direct appropriate imaging and treatment.
Related Concept Videos
Dementia l: Introduction
1
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
1
Dementia
734
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
734
Alzheimer's Disease: Overview
2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
Alzheimer Disease l: Introduction
2
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
2
Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
Alzheimer's Disease: Treatment
1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K


